HSP90AB1 and diffuse large B-cell lymphoma: Similar to the effects of HSP90 inhibitors, doxycycline treatment decreased the levels of several known HSP90 client proteins in DLBCL cells (Figure 5A, Supplementary Figure 3A and 4A), while such treatment had no inhibitory effect on the mRNA levels of these proteins (Supplementary Figure 5A).